Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Janssen Biotech, Inc.

Clinical trials sponsored by Janssen Biotech, Inc., explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

A subsidiary of Johnson & Johnson, developing biotech therapies across multiple disease areas.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 2 Completed 1

New drug cocktail shows promise in slowing advanced prostate cancer

Disease control Completed

This study tested a combination of abiraterone acetate and prednisone in 131 men with advanced prostate cancer that had not yet spread on scans. The goal was to see if the drugs could lower PSA levels and delay cancer progression. Participants took daily pills alongside standard …

Phase: PHASE2 • Sponsor: Janssen Biotech, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC